Skip to main content

Zentalis Pharmaceuticals, Inc.

ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001725160

In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Zentalis Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
134
+24 vs. Q1 2023
Shares held
82.5M
+15.4M (+23.0%) vs. Q1 2023
Total value
$2.32B
+$1.17B (+101.6%) vs. Q1 2023
New holders
34
59 more added
Sold out
10
27 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 134 institutions
Q1 2021: 95 institutionsQ2 2021: 120 institutionsQ3 2021: 116 institutionsQ4 2021: 139 institutionsQ1 2022: 128 institutionsQ2 2022: 122 institutionsQ3 2022: 121 institutionsQ4 2022: 106 institutionsQ1 2023: 110 institutionsQ2 2023: 134 institutionsQ3 2023: 137 institutionsQ4 2023: 120 institutionsQ1 2024: 142 institutionsQ2 2024: 145 institutionsQ3 2024: 136 institutionsQ4 2024: 142 institutionsQ1 2025: 132 institutionsQ2 2025: 117 institutionsQ3 2025: 99 institutionsQ4 2025: 86 institutionsQ1 2026: 102 institutionsQ2 2026: 114 institutions
Value heldQ2 2023: $2.32B
Q1 2021: $1.58BQ2 2021: $2.13BQ3 2021: $2.75BQ4 2021: $3.61BQ1 2022: $2.05BQ2 2022: $1.64BQ3 2022: $1.27BQ4 2022: $1.30BQ1 2023: $1.15BQ2 2023: $2.32BQ3 2023: $1.61BQ4 2023: $1.23BQ1 2024: $1.34BQ2 2024: $314.3MQ3 2024: $261.2MQ4 2024: $195.2MQ1 2025: $92.9MQ2 2025: $64.5MQ3 2025: $79.7MQ4 2025: $54.9MQ1 2026: $101.7MQ2 2026: $228.9M
Institutions holding ZNTL and their total value by quarter
QuarterHoldersValue
Q2 2026114$228.9M
Q1 2026102$101.7M
Q4 202586$54.9M
Q3 202599$79.7M
Q2 2025117$64.5M
Q1 2025132$92.9M
Q4 2024142$195.2M
Q3 2024136$261.2M
Q2 2024145$314.3M
Q1 2024142$1.34B
Q4 2023120$1.23B
Q3 2023137$1.61B
Q2 2023134$2.32B
Q1 2023110$1.15B
Q4 2022106$1.30B
Q3 2022121$1.27B
Q2 2022122$1.64B
Q1 2022128$2.05B
Q4 2021139$3.61B
Q3 2021116$2.75B
Q2 2021120$2.13B
Q1 202195$1.58B

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q1 2023.

Institutions holding ZNTL in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Charles Schwab Investment Management Inc405,845$11.4M0.00%+72,277+21.7%Added
Deutsche Bank AG419,226$11.8M0.01%+374,402+835.3%Added
Integral Health Asset Management, LLC450,000$12.7M1.67%−150,000−25.0%Reduced
Boxer Capital, LLC450,000$12.7M0.59%+450,000New
Northern Trust Corp478,803$13.5M0.00%+51,932+12.2%Added
5AM Venture Management, LLC490,000$13.8M3.44%+490,000New
Morgan Stanley502,875$14.2M0.00%+231,611+85.4%Added
Verition Fund Management LLC507,020$14.3M0.22%+116,438+29.8%Added
Marshall Wace, LLP516,045$14.6M0.03%+516,045New
Adage Capital Partners GP, L.L.C.555,000$15.7M0.03%+555,000New
Capital World Investors683,000$19.3M0.00%00.0%Unchanged
Goldman Sachs Group Inc733,577$20.7M0.01%+529,631+259.7%Added
First Light Asset Management, LLC757,835$21.4M1.68%+757,835New
Sofinnova Investments, Inc.828,005$23.4M1.54%−611,057−42.5%Reduced
Tybourne Capital Management (HK) Ltd961,486$27.1M2.93%−670,803−41.1%Reduced
Geode Capital Management, LLC1,067,601$30.1M0.00%+171,676+19.2%Added
Woodline Partners LP1,094,974$30.9M0.37%−1,070,577−49.4%Reduced
Cormorant Asset Management, LP1,095,000$30.9M1.76%+1,095,000New
Primecap Management Co1,111,150$31.3M0.03%−17,770−1.6%Reduced
Alliancebernstein L.P.1,321,435$37.3M0.02%+31,139+2.4%Added
Wellington Management Group LLP1,908,444$53.8M0.01%−1,451,885−43.2%Reduced
T. Rowe Price Investment Management, Inc.1,999,354$56.4M0.04%−11,055−0.5%Reduced
Federated Hermes, Inc.2,018,234$56.9M0.14%+531,236+35.7%Added
Decheng Capital Management III (Cayman), LLC2,099,583$59.2M18.58%+275,000+15.1%Added
Citadel Advisors LLC2,129,296$60.1M0.07%+799,303+60.1%Added
Avidity Partners Management LP2,334,000$65.8M2.30%−595,300−20.3%Reduced
Price T Rowe Associates Inc2,684,352$75.7M0.01%+484,183+22.0%Added
Capital International Investors3,127,758$88.2M0.02%00.0%Unchanged
State Street Corp3,152,914$88.9M0.00%+320,891+11.3%Added
BlackRock Inc.3,950,804$111.5M0.00%+533,337+15.6%Added
Vanguard Group Inc4,929,173$139.1M0.00%+688,558+16.2%Added
Eventide Asset Management, LLC6,877,803$194.0M3.28%+3,650,803+113.1%Added
FMR LLC10,576,572$298.4M0.03%+1,663,821+18.7%Added
Matrix Capital Management Company, LP13,959,973$393.8M4.58%+4,760,000+51.7%Added
Allspring Global Investments Holdings, LLC0$00.00%−360,151−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−147,923−100.0%Sold out
SEI Investments Co0$00.00%−74,794−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−35,182−100.0%Sold out
Teachers Retirement System of the State of Kentucky0$00.00%−29,865−100.0%Sold out
XTX Topco Ltd0$00.00%−21,215−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−10,918−100.0%Sold out
Sandia Investment Management LP0$00.00%−2,500−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−193−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−89−100.0%Sold out